PMC:7534795 / 92889-93268 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T461","span":{"begin":357,"end":379},"obj":"Body_part"}],"attributes":[{"id":"A461","pred":"fma_id","subj":"T461","obj":"http://purl.org/sig/ont/fma/fma66861"}],"text":"outcomes in the context of COVID-19.\nNumerous studies have demonstrated cardioprotective properties of n-3 PUFA, and their epoxylipid metabolites, involve an ability to preserve a healthy mitochondrial pool and attenuate exaggerated inflammatory responses under stress conditions. For example, n-3 PUFAs could impart a cardioprotective effect via enriching mitochondrial membrane"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T514","span":{"begin":27,"end":35},"obj":"Disease"}],"attributes":[{"id":"A514","pred":"mondo_id","subj":"T514","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"outcomes in the context of COVID-19.\nNumerous studies have demonstrated cardioprotective properties of n-3 PUFA, and their epoxylipid metabolites, involve an ability to preserve a healthy mitochondrial pool and attenuate exaggerated inflammatory responses under stress conditions. For example, n-3 PUFAs could impart a cardioprotective effect via enriching mitochondrial membrane"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T648","span":{"begin":178,"end":179},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T63948","span":{"begin":317,"end":318},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T650","span":{"begin":371,"end":379},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"}],"text":"outcomes in the context of COVID-19.\nNumerous studies have demonstrated cardioprotective properties of n-3 PUFA, and their epoxylipid metabolites, involve an ability to preserve a healthy mitochondrial pool and attenuate exaggerated inflammatory responses under stress conditions. For example, n-3 PUFAs could impart a cardioprotective effect via enriching mitochondrial membrane"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T730","span":{"begin":107,"end":111},"obj":"Chemical"},{"id":"T732","span":{"begin":134,"end":145},"obj":"Chemical"},{"id":"T733","span":{"begin":298,"end":303},"obj":"Chemical"}],"attributes":[{"id":"A730","pred":"chebi_id","subj":"T730","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A731","pred":"chebi_id","subj":"T730","obj":"http://purl.obolibrary.org/obo/CHEBI_76567"},{"id":"A732","pred":"chebi_id","subj":"T732","obj":"http://purl.obolibrary.org/obo/CHEBI_25212"},{"id":"A733","pred":"chebi_id","subj":"T733","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":"outcomes in the context of COVID-19.\nNumerous studies have demonstrated cardioprotective properties of n-3 PUFA, and their epoxylipid metabolites, involve an ability to preserve a healthy mitochondrial pool and attenuate exaggerated inflammatory responses under stress conditions. For example, n-3 PUFAs could impart a cardioprotective effect via enriching mitochondrial membrane"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T231","span":{"begin":233,"end":255},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"outcomes in the context of COVID-19.\nNumerous studies have demonstrated cardioprotective properties of n-3 PUFA, and their epoxylipid metabolites, involve an ability to preserve a healthy mitochondrial pool and attenuate exaggerated inflammatory responses under stress conditions. For example, n-3 PUFAs could impart a cardioprotective effect via enriching mitochondrial membrane"}

{"project":"LitCovid-sentences","denotations":[{"id":"T599","span":{"begin":37,"end":280},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"outcomes in the context of COVID-19.\nNumerous studies have demonstrated cardioprotective properties of n-3 PUFA, and their epoxylipid metabolites, involve an ability to preserve a healthy mitochondrial pool and attenuate exaggerated inflammatory responses under stress conditions. For example, n-3 PUFAs could impart a cardioprotective effect via enriching mitochondrial membrane"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2581","span":{"begin":27,"end":35},"obj":"Disease"},{"id":"2603","span":{"begin":103,"end":111},"obj":"Chemical"},{"id":"2604","span":{"begin":294,"end":303},"obj":"Chemical"}],"attributes":[{"id":"A2581","pred":"tao:has_database_id","subj":"2581","obj":"MESH:C000657245"},{"id":"A2603","pred":"tao:has_database_id","subj":"2603","obj":"MESH:D015525"},{"id":"A2604","pred":"tao:has_database_id","subj":"2604","obj":"MESH:D015525"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"outcomes in the context of COVID-19.\nNumerous studies have demonstrated cardioprotective properties of n-3 PUFA, and their epoxylipid metabolites, involve an ability to preserve a healthy mitochondrial pool and attenuate exaggerated inflammatory responses under stress conditions. For example, n-3 PUFAs could impart a cardioprotective effect via enriching mitochondrial membrane"}